Sputum IL-6 concentrations in severe asthma and its relationship with FEV1
Morjaria, J .B., Babu, K .S., Vijayanand, P., Chauhan, A.J., Davies, D.E. and Holgate, S. (2011) Sputum IL-6 concentrations in severe asthma and its relationship with FEV1. Thorax, 66 (6), 537. (doi:10.1136/thx.2010.136523). (PMID:20880874).
Full text not available from this repository.
As asthma becomes more severe it adopts additional characteristics including corticosteroid refractoriness and a neutrophil-predominant inflammatory response implicating Th1 or Th17 responses involving cytokines such as tumour necrosis factor α, interleukin (IL)-6 and IL-8. We have examined the role of IL-6 and IL-8 in severe asthma. Subjects with severe asthma (GINA stage IV) who were exacerbation-free for ≥4 weeks with a forced expiratory volume in 1 s (FEV 1) >30% but <80% predicted were studied from the baseline parameters of a clinical trial. 1 Cell counts and cytokines were measured in induced sputum (see online supplement for Methods).
Eighteen subjects (9M, 9F) with severe asthma (mean±SD age 43.4±11.4 years (1SD), FEV 1 59±14% predicted) were studied (see table 1 in online appendix). The median (IQR) levels of sputum IL-8, IL-6, neutrophils (%), macrophages (%) and eosinophils (%) were 1853.8 pg/ml (1376.8–2537.7), 70.0 pg/ml (28.55–127.5), 32.5% (24.1–42.6), 46.8% (39.8–54.8) and 4.4% (3.2–9.4), respectively. We observed significant negative correlations between FEV 1 …
|Subjects:||Q Science > QR Microbiology > QR180 Immunology
R Medicine > RB Pathology
R Medicine > RF Otorhinolaryngology
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Infection, Inflammation and Repair
|Date Deposited:||17 May 2011 09:23|
|Last Modified:||19 Jul 2012 10:28|
|Contributors:||Morjaria, J .B. (Author)
Babu, K .S. (Author)
Vijayanand, P. (Author)
Chauhan, A.J. (Author)
Davies, D.E. (Author)
Holgate, S. (Author)
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)